Home › Funds › Metavasi Capital LP › TWST
Metavasi Capital LP position in TWST
TWIST BIOSCIENCE CORP · Health Care
Metavasi Capital LP reported holding 176,004 shares of TWST (TWIST BIOSCIENCE CORP) in its Q2 2026 13F filing — a position valued at US$18.1M, representing 6.78% of its reported portfolio and ranking #5 among its reported holdings. Metavasi Capital LP has disclosed TWST holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Metavasi Capital LP's TWST position evolved
Metavasi Capital LP first disclosed a stake in TWST in Q1 2026 at 100,000 shares (US$4.8M). The position peaked in Q2 2026 at 176,004 shares, worth US$18.1M. Across 2 filings, Metavasi Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 176,004 shares valued at US$18.1M — an increase of 76,004 shares quarter over quarter.. Notable position changes include a 76% increase in Q2 2026 (shares rose 88% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.00K | $4.75M | New |
| Q2 2026 | 176.00K | $18.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TWST and 13F data
TWST (TWIST BIOSCIENCE CORP) is a Health Care company. 57 other funds we track also report a position in TWST — the largest reported positions include Artisan Partners Limited Partnership (US$494.0M), ARK Invest (US$468.1M), EdgePoint Investment Group Inc. (US$259.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TWST
- Artisan Partners Limited Partnership 4.80M sh · $494.03M · Q2 2026
- ARK Invest 4.55M sh · $468.08M · Q2 2026
- EdgePoint Investment Group Inc. 2.52M sh · $259.43M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.17M sh · $223.72M · Q2 2026
- Farallon Capital Management 2.14M sh · $219.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.14M sh · $219.79M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.02M sh · $105.20M · Q2 2026
- Amova Asset Management Americas, Inc. 999.73K sh · $102.84M · Q2 2026
- Stephens Investment Management Group LLC 767.36K sh · $78.95M · Q2 2026
- First Light Asset Management, LLC 727.93K sh · $74.89M · Q2 2026
- Tao Capital Management LP 478.81K sh · $49.26M · Q2 2026
- Granahan Investment Management, LLC 314.88K sh · $32.40M · Q2 2026
More on Metavasi Capital LP
FAQ
How long has Metavasi Capital LP held TWST?
Metavasi Capital LP has disclosed TWST holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Metavasi Capital LP's current position in TWST?
As of Q2 2026, Metavasi Capital LP holds 176.00K shares of TWST (TWIST BIOSCIENCE CORP), valued at $18.11M, representing 6.78% of its reported portfolio and ranking #5.
Has Metavasi Capital LP been buying or selling TWST?
In the latest 13F filing (Q2 2026), Metavasi Capital LP increased its position in TWST. The position peaked in Q2 2026 at 176.00K shares.
Which other funds hold TWST?
Other major institutional holders of TWST include Artisan Partners Limited Partnership, ARK Invest, EdgePoint Investment Group Inc., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.